• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合方法对C群脑膜炎球菌多糖-P64k蛋白结合物免疫原性和保护效力的影响。

Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates.

作者信息

Carmenate Tania, Canaán Leonardo, Alvarez Anabel, Delgado Maité, González Sonia, Menéndez Tamara, Rodés Lorenzo, Guillén Gerardo

机构信息

Centre for Genetic Engineering and Biotechnology, Division of Vaccines, PO Box 6162, Havana 6, Cuba.

出版信息

FEMS Immunol Med Microbiol. 2004 Apr 9;40(3):193-9. doi: 10.1016/S0928-8244(03)00346-8.

DOI:10.1016/S0928-8244(03)00346-8
PMID:15039094
Abstract

Neisseria meningitidis serogroup C polysaccharide (CCPS) was conjugated to the carrier protein P64k using two different conjugation procedures, condensation mediated by carbodiimide with adipic acid dihydrazide as spacer and the reductive amination method. BALB/c mice were immunized with the resultant polysaccharide-protein conjugates and the immune response was evaluated. All conjugates assayed generated at least 10-fold higher antibody titers than the free polysaccharide. The reductive amination method rendered the best conjugate (CCPS-P64kR) that was able to elicit antibody titers statistically higher than the titer elicited by the plain CCPS (P<0.001). The sera of the group immunized with CCPS-P64kR showed a three-fold higher bactericidal response than the sera of the group immunized with the plain CCPS and they were able to protect against challenge with meningococci in the infant rat protection model. In addition, three different conjugates were obtained from polysaccharides with molecular relative sizes of 2000-4000 Da, 4000-10,000 Da or 10,000-50,000 Da, but no differences were detected in the immune response obtained against the three conjugates. Our experiments demonstrate that it is possible to generate a protective, T-cell-dependent response against CCPS using the P64k protein as carrier.

摘要

使用两种不同的偶联方法,即碳二亚胺介导的缩合反应(以己二酸二酰肼为间隔臂)和还原胺化法,将脑膜炎奈瑟菌C群多糖(CCPS)与载体蛋白P64k偶联。用所得的多糖-蛋白偶联物免疫BALB/c小鼠,并评估免疫反应。所有检测的偶联物产生的抗体滴度比游离多糖至少高10倍。还原胺化法得到的最佳偶联物(CCPS-P64kR)能够引发统计学上高于纯CCPS引发滴度的抗体滴度(P<0.001)。用CCPS-P64kR免疫的组的血清杀菌反应比用纯CCPS免疫的组的血清高3倍,并且它们能够在幼鼠保护模型中抵御脑膜炎球菌的攻击。此外,从分子量相对大小为2000-4000 Da、4000-10,000 Da或10,000-50,000 Da的多糖中获得了三种不同的偶联物,但针对这三种偶联物获得的免疫反应未检测到差异。我们的实验表明,使用P64k蛋白作为载体有可能产生针对CCPS的保护性、T细胞依赖性反应。

相似文献

1
Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates.结合方法对C群脑膜炎球菌多糖-P64k蛋白结合物免疫原性和保护效力的影响。
FEMS Immunol Med Microbiol. 2004 Apr 9;40(3):193-9. doi: 10.1016/S0928-8244(03)00346-8.
2
Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine.在埃塞俄比亚猕猴体内产生的针对C群脑膜炎球菌多糖结合疫苗的记忆免疫反应。
FEMS Immunol Med Microbiol. 2005 Feb 1;43(2):133-40. doi: 10.1016/j.femsim.2004.07.003.
3
Immunologic memory response induced by a meningococcal serogroup C conjugate vaccine using the P64k recombinant protein as carrier.以P64k重组蛋白为载体的C群脑膜炎球菌结合疫苗诱导的免疫记忆反应。
FEMS Immunol Med Microbiol. 2006 Mar;46(2):169-79. doi: 10.1111/j.1574-695X.2005.00025.x.
4
Safety and preliminary immunogenicity of MenC/P64k, a meningococcal serogroup C conjugate vaccine with a new recombinant carrier.新型重组载体的C群脑膜炎球菌结合疫苗MenC/P64k的安全性和初步免疫原性
FEMS Immunol Med Microbiol. 2006 Apr;46(3):386-92. doi: 10.1111/j.1574-695X.2006.00047.x.
5
Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.佐剂可以增强OMV疫苗对新生小鼠B/C群脑膜炎奈瑟菌的免疫保护作用。
FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):205-10. doi: 10.1016/j.femsim.2004.03.005.
6
New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.新型脑膜炎球菌C多糖-破伤风类毒素结合物:理化及免疫学特性
Vaccine. 2007 Feb 26;25(10):1798-805. doi: 10.1016/j.vaccine.2006.11.029. Epub 2006 Dec 5.
7
Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.两种不同的方法导致了能诱导针对C群脑膜炎奈瑟菌产生保护性抗体反应的肽段的选择。
J Immunol Methods. 2004 Feb 1;285(1):1-14. doi: 10.1016/j.jim.2003.08.005.
8
Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.既往多糖疫苗接种对成人C群脑膜炎球菌破伤风类毒素结合疫苗免疫反应的强度、持续时间、质量及安全性的影响
Clin Diagn Lab Immunol. 2004 Nov;11(6):1100-4. doi: 10.1128/CDLI.11.6.1100-1104.2004.
9
Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.来自B群脑膜炎奈瑟菌的脂蛋白NMB0928作为一种新型疫苗候选物。
Vaccine. 2007 Dec 5;25(50):8420-31. doi: 10.1016/j.vaccine.2007.09.053. Epub 2007 Oct 11.
10
Optimization of the conjugation method for a serogroup B/C meningococcal vaccine.
Biotechnol Appl Biochem. 2006 Nov;45(Pt 3):141-6. doi: 10.1042/BA20060041.

引用本文的文献

1
Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines.探索影响传统和创新糖缀合物疫苗免疫反应的变量。
Front Mol Biosci. 2023 May 16;10:1201693. doi: 10.3389/fmolb.2023.1201693. eCollection 2023.
2
A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine, SCTV01A, Showed High Immunogenicity and Low Toxicity in Animal Models.一种多糖-RBD-Fc缀合的COVID-19疫苗SCTV01A在动物模型中显示出高免疫原性和低毒性。
Vaccines (Basel). 2023 Feb 23;11(3):526. doi: 10.3390/vaccines11030526.
3
Impact and Control of Sugar Size in Glycoconjugate Vaccines.
糖大小对糖缀合物疫苗的影响和控制。
Molecules. 2022 Sep 29;27(19):6432. doi: 10.3390/molecules27196432.
4
Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines.聚糖链长度和连接类型对糖结合疫苗免疫原性的联合影响。
NPJ Vaccines. 2021 Dec 10;6(1):150. doi: 10.1038/s41541-021-00409-1.
5
Synthesis, LC-MS/MS analysis, and biological evaluation of two vaccine candidates against ticks based on the antigenic P0 peptide from R. sanguineus linked to the p64K carrier protein from Neisseria meningitidis.基于与脑膜炎奈瑟菌 p64K 载体蛋白相连的抗原 P0 肽,合成、LC-MS/MS 分析和两种抗蜱疫苗候选物的生物学评价。
Anal Bioanal Chem. 2021 Sep;413(23):5885-5900. doi: 10.1007/s00216-021-03569-0. Epub 2021 Aug 3.
6
Rational Design of a Glycoconjugate Vaccine against Group A .针对 A 群链球菌的糖缀合物疫苗的合理设计
Int J Mol Sci. 2020 Nov 13;21(22):8558. doi: 10.3390/ijms21228558.
7
Co-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses.通过共价脂质体连接与表面排列的 B 细胞靶抗原共递呈 CD4 T 细胞辅助表位可促进更高亲和力的抗体反应。
Vaccine. 2018 Oct 1;36(41):6191-6201. doi: 10.1016/j.vaccine.2018.08.014. Epub 2018 Sep 7.
8
Site-specific scFv labelling with invertase via Sortase A mechanism as a platform for antibody-antigen detection using the personal glucose meter.通过分选酶A机制将蔗糖酶进行位点特异性单链抗体片段标记,作为使用个人血糖仪进行抗体-抗原检测的平台。
Sci Rep. 2016 Jan 19;6:19338. doi: 10.1038/srep19338.
9
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.开发一种糖缀合物疫苗,以预防非洲由脑膜炎奈瑟菌血清群 X 引起的脑膜炎。
Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19077-82. doi: 10.1073/pnas.1314476110. Epub 2013 Nov 4.
10
Purified capsular polysaccharide of Neisseria meningitidis serogroup A as immune potentiator for antibody production.A 群脑膜炎奈瑟菌荚膜多糖的纯化作为抗体产生的免疫增强剂。
Curr Microbiol. 2010 Feb;60(2):79-84. doi: 10.1007/s00284-009-9505-9. Epub 2009 Sep 23.